LTRN Earnings — Lantern Pharma Inc. Common Stock Post-ER Performance | BigEarnings
LTRN — Lantern Pharma Inc. Common Stock
XNAS
Price$3.59
Market Cap$45.8M
P/E—
52W Range$1.11 – $5.74
Next Earnings2026-08-12
About Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
